News

Summit Therapeutics to Host Utrophin R&D Day 15 June 2016


TRY IT NOW

Sign up online today & collaborate

or click here to find out more

Summit Therapeutics to Host Utrophin R&D Day 15 June 2016

07/06/2016

 

Oxford, UK – Summit Therapeutics plc, the drug discovery and development company advancing therapies for Duchenne muscular dystrophy (‘DMD’) and

This event is open to analysts, institutional investors and members of the press. For more information, email

A live audio webcast of the presentation will be available through the Investors section on the Company’s website,


CompanySummit Therapeutics plc
Company Websitehttp://www.summitplc.com/

© Catalyst Innovation Portal 2019